다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Lexeo Therapeutics Inc (LXEO)
Lexeo Therapeutics Inc (LXEO) 뉴스

LXEO

Lexeo Therapeutics (LXEO)

Lexeo Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LXEO

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/22	07:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/02/22	07:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/02/22	07:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/02/22	07:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/02/20	06:25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/02/20	06:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/02/20	06:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/02/20	06:06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/02/12	23:35	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/02/05	05:45	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/01/23	06:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/01/13	21:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/01/11	06:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/01/11	06:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/01/11	06:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/01/11	06:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/01/11	06:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2025/01/07	21:30	GlobeNewswire Inc.	Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/12/28	04:59	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/12/20	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/12/19	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/12/19	21:00	GlobeNewswire Inc.	Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/12/13	22:19	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/12/13	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/12/11	07:18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/12/04	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/12/03	07:04	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/11/14	07:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/11/13	21:35	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/11/13	21:33	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LXEO	Lexeo Therapeutics Inc

검색 관련기사 보기:NASDAQ:LXEO

1 2 3 다음 >>

Financial Select Sector

Invesco QQQ Trust Series 1

American Express

Deutsche Telekom (QX)

BNP Paribas (QX)

Health Care Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관